AU2002213267A1 - 6-o-substituted erythromycin derivatives having improved gastrointestinal tolerance - Google Patents

6-o-substituted erythromycin derivatives having improved gastrointestinal tolerance

Info

Publication number
AU2002213267A1
AU2002213267A1 AU2002213267A AU1326702A AU2002213267A1 AU 2002213267 A1 AU2002213267 A1 AU 2002213267A1 AU 2002213267 A AU2002213267 A AU 2002213267A AU 1326702 A AU1326702 A AU 1326702A AU 2002213267 A1 AU2002213267 A1 AU 2002213267A1
Authority
AU
Australia
Prior art keywords
erythromycin derivatives
gastrointestinal tolerance
improved gastrointestinal
substituted erythromycin
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002213267A
Inventor
Richard F. Clark
Stevan Djuric
Zhenkun Ma
Ly Tam Pham
Souming Zhang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Publication of AU2002213267A1 publication Critical patent/AU2002213267A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
AU2002213267A 2000-10-16 2001-10-16 6-o-substituted erythromycin derivatives having improved gastrointestinal tolerance Abandoned AU2002213267A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24077700P 2000-10-16 2000-10-16
US60/240,777 2000-10-16
PCT/US2001/032278 WO2002032919A2 (en) 2000-10-16 2001-10-16 6-o-substituted erythromycin derivatives having improved gastrointestinal tolerance

Publications (1)

Publication Number Publication Date
AU2002213267A1 true AU2002213267A1 (en) 2002-04-29

Family

ID=22907903

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002213267A Abandoned AU2002213267A1 (en) 2000-10-16 2001-10-16 6-o-substituted erythromycin derivatives having improved gastrointestinal tolerance

Country Status (9)

Country Link
EP (1) EP1328534A2 (en)
JP (1) JP2004529857A (en)
AU (1) AU2002213267A1 (en)
BR (1) BR0109946A (en)
CA (1) CA2420012A1 (en)
MX (1) MXPA03003311A (en)
PE (1) PE20020522A1 (en)
UY (1) UY26964A1 (en)
WO (1) WO2002032919A2 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2469304A1 (en) 2001-12-05 2003-06-19 Ortho-Mcneil Pharmaceutical, Inc. 6-o acyl ketolide antibacterials
JP2005529143A (en) * 2002-04-30 2005-09-29 アボット・ラボラトリーズ Antibacterial compounds with improved pharmacokinetic profiles
US6727229B2 (en) * 2002-08-19 2004-04-27 Enanta Pharmaceuticals, Inc. 11,12-substituted lactone ketolide derivatives having antibacterial activity
WO2004078771A1 (en) * 2003-03-07 2004-09-16 Taisho Pharmaceutical Co., Ltd. 2-fluoro-6-o-substituted ketolide derivative
JP2007223900A (en) * 2004-02-03 2007-09-06 Taisho Pharmaceut Co Ltd 6-o-substituted ketolide derivative
JP2007254285A (en) * 2004-03-16 2007-10-04 Taisho Pharmaceut Co Ltd 2-fluoro-6-o-substituted ketolide derivative
WO2007091393A1 (en) 2006-02-07 2007-08-16 Taisho Pharmaceutical Co., Ltd. 10a-AZALIDE COMPOUND
US8293715B2 (en) 2007-08-06 2012-10-23 Taisho Pharmaceutical Co., Ltd. 10a-Azalide compound crosslinked at 10a- and 12-positions
JPWO2009139181A1 (en) 2008-05-15 2011-09-15 大正製薬株式会社 10a-azalide compound having a 4-membered ring structure
CN102234302B (en) * 2010-05-07 2014-05-07 北京理工大学 Novel ketolide derivatives, and preparation method and medicinal compositions thereof
AR085286A1 (en) 2011-02-21 2013-09-18 Taisho Pharmaceutical Co Ltd MACROLIDO DERIVATIVE REPLACED IN POSITION C-4
AR102810A1 (en) 2014-08-18 2017-03-29 Taisho Pharmaceutical Co Ltd MACROLID DERIVATIVE REPLACED IN POSITION C-4

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6054435A (en) * 1999-03-19 2000-04-25 Abbott Laboratories 6-O-substituted macrolides having antibacterial activity

Also Published As

Publication number Publication date
JP2004529857A (en) 2004-09-30
EP1328534A2 (en) 2003-07-23
CA2420012A1 (en) 2002-04-25
MXPA03003311A (en) 2003-09-10
UY26964A1 (en) 2002-06-20
BR0109946A (en) 2005-08-02
PE20020522A1 (en) 2002-06-25
WO2002032919A3 (en) 2002-09-19
WO2002032919A2 (en) 2002-04-25

Similar Documents

Publication Publication Date Title
EP1363925B8 (en) Macrolide antibiotics
AU2002217277A1 (en) Macrolide antibiotics
AU2001272719A1 (en) Macrolide antibiotics
MXPA03005028A (en) 6-0-carbamoyl ketolide derivatives of erythromycin useful as antibacterials.
ZA985018B (en) 9-oxime erythromycin derivatives.
SI1147121T1 (en) Ketolide antibiotics
IL161710A0 (en) Macrolides
AU2001250648A1 (en) Plasticizer
AU2001278694A1 (en) Avermectin derivatives
ZA200107346B (en) Erythromycin derivatives.
AU2002213267A1 (en) 6-o-substituted erythromycin derivatives having improved gastrointestinal tolerance
AU6183700A (en) Erythromycin a derivatives
AU2002230386A1 (en) Sixteen-membered macrolide compounds
AU2002346600A1 (en) 11-o-substituted macrolides and their descladinose derivatives
AU6316400A (en) Erythromycin a derivatives
AU6183800A (en) Erythromycin a derivatives
EP1333807A4 (en) Extended release erythromycin derivatives
AU2971100A (en) Parenteral metolazone formulations
AU2001290475A1 (en) Crash barrier
AU2002215965A1 (en) Pyranoside derivatives
AU2001285568A1 (en) Mucin
AU2001227804A1 (en) Plasticizer
AU2002232183A1 (en) 12- and 13-modified novel 16-membered macrolide derivatives
GB0031314D0 (en) Macrolides
GB0025691D0 (en) Macrolides